The global amniotic membrane market is set for significant growth, with estimates predicting a valuation of USD 1,510.6 million in 2024. The market is expected to exceed USD 2,279.5 million by 2034, reflecting a compound annual growth rate (CAGR) of 4.2% over the forecast period.
The rising demand for amniotic membranes is largely driven by their therapeutic potential across a range of medical applications. These membranes are increasingly utilized in wound healing, ophthalmology, and tissue regeneration due to their unique properties and benefits. The expansion of their use in these areas is fueling the market’s robust growth trajectory.
The increasing demand for amniotic membranes is driven by their significant therapeutic potential across various medical fields, including wound healing, ophthalmology, and tissue regeneration. These membranes are valued for their unique properties, which support rapid tissue repair and regeneration, making them a vital component in advanced medical treatments.
The population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic about increasing amniotic membrane transplants and increasing demand for amniotic membrane products worldwide, particularly in North American countries. It is more than likely that over the next four to five years, the companies focus on developing innovative products and designing market-level strategies to leverage the potential opportunities emerging in parallel with the growing human population with various chronic diseases.
Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membranes and lyophilized amniotic membranes evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.
The global amniotic membrane market has been segmented based on product type, application, end-user and region. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory properties. Among all end users of amniotic membranes, high demand for amniotic membranes is expected to come from the hospital segment due to the rising application of amniotic membranes in advanced surgical healing.
By volume
The global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to the penetration of newly approved products in the U.S. Western Europe, the second largest market globally, with the U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third-largest market for amniotic membranes. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.
The market for amniotic membranes is highly consolidated with the top 5 players contributing over 60% of the revenue share in 2017.
Examples of some of the key players identified in the Amniotic Membrane Market are Integra
- LifeSciencesm Inc.
- MiMedx Group, Inc.
- Alliqua BioMedical, Inc.
- Skye Biologics Inc.
- Katena Products, Inc.
- Tissue-Tech Inc.
- Amnio Technology, LLC
- Applied Biologics LLC
- Human Regenerative Technologies, LLC
Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market
Some of the key points identified in the Amniotic Membrane Market are:
- Market Valuation: The global amniotic membrane market is estimated to be US$ 1,510.6 million in 2024.
- Future Projections: By 2034, the market is forecasted to exceed a valuation of US$ 2,279.5 million, recording a CAGR of 4.2%.
- Therapeutic Potential: Amniotic membrane demand is primarily fueled by its therapeutic potential, particularly in wound healing, ophthalmology, and tissue regeneration.
Key Segments of Amniotic Membrane Market Survey
by Product Type:
- Cryopreserved Amniotic Membranes
- Lyophilized Amniotic Membranes
by Application:
- Surgical Wounds
- Ophthalmology
- Others
by End User:
- Amniotic Membrane Treatment in Hospitals
- Amniotic Membrane Treatment in Specialized Clinics
- Amniotic Membrane Treatment in Ambulatory Surgical Centres
- Amniotic Membrane Treatment in Academic Research Centres
by Region:
- North America Amniotic Membranes Market
- Latin America Amniotic Membranes Industry
- Europe Amniotic Membranes Market
- East Asia Amniotic Membranes Industry
- South Asia & Pacific Amniotic Membranes Market
- Middle East & Africa (MEA) Amniotic Membranes Industry
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
